Friday, June 17, 2011

Google Alert - cell lung cancer

News5 new results for cell lung cancer
 
Pfizer Lung-Cancer Drug Seen Approved in Q4
Barron's
Amongst the multitude of lung-cancer presentations, Pfizer's oral crizotinib (an ALK inhibitor) was touted as a breakthrough and was reflective of the focus on personalized medicine. Crizotinib was designed for non-small cell lung-cancer (NSCLC) ...
See all stories on this topic »
WASHTENAW COUNTY: Local volunteers sought for cancer study
Heritage Newspapers
By Sheila Pursglove, Special Writer Carol Yarrington's personal story with cancer started 22 years ago, when her mother was diagnosed with lung cancer. "She was taken from me quickly. Her eight grandchildren missed out on growing up with a special lady ...
See all stories on this topic »

Heritage Newspapers
Mature Autologous Dendritic Cell Vaccines in Advanced Non-Small Cell Lung ...
7thSpace Interactive (press release)
Overall therapeutic outcomes of advanced non-small-cell lung cancer (NSCLC) are poor. The dendritic cell (DC) immunotherapy has been developed as a new strategy for the treatment of lung cancer. The purpose of this study was to evaluate the feasibility ...
See all stories on this topic »
Proteins may explain why some people exposed to asbestos develop mesothelioma
Mesothelioma.com
Asbestos is a highly carcinogenic mineral fiber that is known to cause several types of cancer, but predominantly lung cancer and mesothelioma, which affects that protective lining of the lungs, heart, chest and abdomen. In fact, prolonged asbestos ...
See all stories on this topic »
ESU alum Randal Scott included on sesquicentennial scientist list
Emporia Gazette
Since the company's founding in 2000, work has focused on breast cancer. Additional work with colon cancer began in 2009. In January of this year, work began with prostate cancer. The company's researchers also are studying non-small cell lung cancer, ...
See all stories on this topic »


This once a day Google Alert is brought to you by Google.

Remove this alert.
Create another alert.
Manage your alerts.

No comments:

Post a Comment